SBIR/STTR Research Award

SBIR Phase I: Development of A Novel Visible-Light Phase Shifter and Intraocular Lens to Improve Vision for Those With Age-Related Macular Degeneration

Award identifier fea9d6f58b6f34aa12612f7a1b4ddca867f0cc78521ef03908dedc82ca5028b7Awarding agency National Science Foundation

Award amount

$304,998

Program and phase

SBIR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
Glaive Medical Inc
Proposal award date
2025-10-01
Contract end date
2026-09-30
UEI
CB96FB25D4M3
Solicitation number
NSF 24-579
Topic code
MD

Research abstract

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a novel implantable lens for shifting the phase of visible-light phase to mitigate vision loss due to age related macular degeneration and damaged retinal regions. Age-related macular degeneration is a chronic and progressive eye disease affecting more than 20 million people in the US and 200 million people worldwide and often results in irreversible blindness. No permanent solution currently exists for treating age-related macular degeneration and mitigating vision loss until surgical interventions may be required. This proposed system aims to provide a permanent means for shifting the area of focus of visible light onto a viable region of the retina for restoring vision to help patients complete common everyday activities, reduce costs of care associated with vision loss and reduce the resulting emotional or health-related burden of macular degeneration. This Small Business Innovation Research (SBIR) Phase I project aims to complete the development of an electronic implantable intraocular lens through a novel implantable low power rechargeable visible-light phase shifter and subsequent optical phased arrays. Current optical phased arrays require high-power consumption with a large footprint, impeding their effectiveness in a commercializable, fully implantable biocompatible device. This project aims to address several critical technical hurdles by developing an energy-efficient metal-oxide-semiconductor capacitor, small-form factor optical phased array in an intraocular implantable device capable of electronically adjusting and shifting visible light frequencies to alternative viable regions of the retina. The study team will conduct systematic modeling to map the performance of key functions and determine the optimal waveguide geometry. Once finalized, the study team will fabricate the devices and measure their performance using standard optical benchmarking measurements relative to a reference waveguide. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.